Introducing new capabilities to GPT-Rosalind
OpenAI introduces a new model update to GPT-Rosalind, designed for life sciences research at enterprise scale. The updated model combines GPT-5.5's agentic coding and tool-use capabilities with stronger model intelligence in core drug-discovery domains such as medicinal chemistry and genomics. GPT-Rosalind shows broad performance gains on research tasks from biology experts, complex medicinal chemistry queries, quantitative biology, and wet lab troubleshooting.
入选理由:GPT-Rosalind combines GPT-5.5's agentic coding and tool-use capabilities with stronger model intelligence in core drug-discovery domains.






